Outlook Therapeutics, Inc. · NASDAQ:OTLK

Sukhtian Ghiath M. bought 2,525,252 Outlook Therapeutics, Inc. shares (Form 4)

Traded Aug 12, 2026 · Filed Aug 14, 2026

On Aug 12, 2026, Sukhtian Ghiath M. (Director, 10% owner) bought 2,525,252 Outlook Therapeutics, Inc. shares at US$0.99 for US$2.5M, leaving 24,617,320 shares. Filed Aug 14, 2026 (Form 4).

Bought
2,525,252 shares
Price
US$0.99
Value
US$2.5M
Holding after
24,617,320 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 12, 2026Common StockBuy2,525,252US$0.9924,617,320Indirect

Source

View original at SEC

Related